“Pembrolizumab-Associated Anti-MDA5 Dermatomyositis in a Patient With Lung Cancer: A First Case Report”. Swiss Medical Weekly, vol. 154, no. 3, Mar. 2024, p. 3513, https://doi.org/10.57187/s.3513.